Elizabeth Jensen, DO
Family Medicine · Sioux Falls, SDNPI 1780695437
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 5 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 4 manufacturers reported payments, led by AstraZeneca at 52.3% of the total. Reporting peaked in 2024 at $73 and has fallen 79.3% since, to $15 in 2025. That places this record below the midpoint for family medicine clinicians in SD, where the typical reported total is $204.
Across 5 payments — averaging $22.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$58
- Shire North American Group Inc$23
- Sanofi$15
- Novo Nordisk$15
Across 8 payments — averaging $16,228 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$82K
- Eli Lilly$48K
What the payments were for
- Food & beverage$111100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 1 | $58 |
| Shire North American Group Inc | 2 | $23 |
| Sanofi | 1 | $15 |
| Novo Nordisk | 1 | $15 |
How this compares
$111 in reported general payments places this provider in the 30th percentile of 408 family medicine providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carbamazepine | 12 | $1,581 |
| LevocarnitineLevocarnitine (With Sugar) | 32 | $1,073 |
| Naltrexone Hcl | 12 | $373 |
| Bupropion XlBupropion Hcl | 24 | $242 |
| Divalproex Sodium ErDivalproex Sodium | 12 | $207 |
| Atorvastatin Calcium | 17 | $190 |
| Warfarin Sodium | 29 | $170 |
| Rosuvastatin Calcium | 14 | $109 |
| Chlorhexidine Gluconate | 21 | $101 |
| Amlodipine Besylate | 19 | $89 |
| Lisinopril | 11 | $56 |
| Risperidone | 12 | $20 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Sioux Falls
- Andrew BurchettSioux Falls$13K
- Lornell HansenSioux Falls$11K
- Jeffry MeyerSioux Falls$8K
- Scott BoyensSioux Falls$6K
- Jason WurthSioux Falls$4K
- Dustin SnellingSioux Falls$4K
- William BuchnerSioux Falls$3K
- Jennifer SchrieverSioux Falls$2K
- Sabrina TaylorSioux Falls$2K
- Nicole MourelatosSioux Falls$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.